| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | 1 | 2 vials | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT26964WQ-2OMe is a type of small interfering RNA (siRNA) that targets NRXN3 gene and regulates the expression of gene. The siRNA interferes with the expression of NRXN3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT26964WQ-2OMe is a type of small interfering RNA (siRNA) that targets NRXN3 gene and regulates the expression of gene. The siRNA interferes with the expression of NRXN3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Researchers at the Creative Biolabs have developed BALB/c Mouse PBMCs that allows for study in numerous research areas, such as immunology, oncology. The cells can be used for a wide variety of safety assessment and functional assays. | Creative Biolabs offers a range of recombinant cell lines for Immunotherapy discovery and development. | This product is a 40.8 kDa Human CCR8 membrane protein expressed in Baculovirus/Insect expression system. The protein is for research use only and is not approved for use in humans or in clinical diagnosis. | The product SIRGT34137WQ-LNA is a type of small interfering RNA (siRNA) that targets NFE2L3 gene and regulates the expression of gene. The siRNA interferes with the expression of NFE2L3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT34137WQ-LNA is a type of small interfering RNA (siRNA) that targets NFE2L3 gene and regulates the expression of gene. The siRNA interferes with the expression of NFE2L3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |